1y return+29.4%S&P 500 +20.9%
These returns are for its stock picks as disclosed on Form 13F: last quarter's holdings, valued at this quarter's prices. They miss trades within each quarter, short positions, options, bonds, cash and fees, so they aren't the returns its clients got.
$100 invested in its stock picks
Since June 30, 2024: $66 against $137 in the S&P 500.2
Versant Venture Management, LLCS&P 500 (SPY)
Top holdings
At the end of June 30, 2026. Change is in shares since the quarter before.2
| Stock | Value | Share of portfolio | Change |
|---|---|---|---|
| GLUEMonte Rosa Therapeutics, Inc. | $77.0M | 47.3% | |
| IPSCCentury Therapeutics, Inc. | $29.8M | 18.3% | |
| JBIOJade Biosciences, Inc. | $22.0M | 13.6% | −35.0% |
| LENZLenz Therapeutics, Inc. | $15.1M | 9.3% | |
| CTNMContineum Therapeutics, Inc. | $8.9M | 5.5% | |
| CRISPR Therapeutics AGCUSIP H17182108 | $8.1M | 5.0% | |
| Skye Bioscience, Inc.CUSIP 83086J200 | $1.4M | 0.9% | |
| Tempest Therapeutics, Inc.CUSIP 87978U108 | $299K | 0.2% |
Best picks still held
How each current holding has done since the quarter it first appeared in its filings (up to six years back).
| Stock | Held since | Return since | Now worth |
|---|---|---|---|
| GLUEMonte Rosa Therapeutics, Inc. | December 31, 2024 | +248.7% | $77.0M |
| JBIOJade Biosciences, Inc. | June 30, 2025 | +122.4% | $22.0M |
| IPSCCentury Therapeutics, Inc. | March 31, 2026 | +8.4% | $29.8M |
| CTNMContineum Therapeutics, Inc. | June 30, 2024 | −6.9% | $8.9M |
| CRISPR Therapeutics AGCUSIP H17182108 | June 30, 2020 | −25.8% | $8.1M |
| LENZLenz Therapeutics, Inc. | September 30, 2025 | −87.8% | $15.1M |
Quarter by quarter
| Quarter | Its picks | S&P 500 |
|---|---|---|
| June 30, 2026 | +23.6% | +14.8% |
| March 31, 2026 | −11.3% | −4.6% |
| December 31, 2025 | −12.0% | +2.4% |
| September 30, 2025 | +34.2% | +7.8% |
| June 30, 2025 | +18.1% | +10.5% |
| March 31, 2025 | −31.3% | −4.6% |
| December 31, 2024 | −27.1% | +2.1% |
| September 30, 2024 | −14.3% | +5.4% |
| September 30, 2023 | −3.1% | −3.6% |
| June 30, 2023 | +17.4% | +8.3% |
| March 31, 2023 | −0.7% | +7.0% |
| December 31, 2022 | −16.2% | +7.1% |
| September 30, 2022 | −10.1% | −5.3% |
| June 30, 2022 | −21.4% | −16.5% |
| December 31, 2021 | −15.3% | +10.7% |
| September 30, 2021 | −18.0% | +0.3% |
Sources
Every number on this page points here. Each one links to the public record.
- 1SEC EDGAR: Versant Venture Management, LLC Form 13F filingshttps://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1560009&type=13F-HR&dateb=&owner=include&count=40CIK 1560009
- 2SEC: 13F for the quarter ended June 30, 2026https://www.sec.gov/Archives/edgar/data/1560009/000119312526347068/Filed August 12, 2026 · accession 0001193125-26-347068